Promed announcement



Date: Tue, 06 Feb 2001 20:34:16 -0500

From: Jan Lundström <Jan.Lundstrom@zoologi.uu.se>

Subject: Information about facilities for experimental infections in animals, creation of a facility for experimental studies of zoonotic pathogens in their natural bird and mammal host species - request for information

Jan O Lundström
Uppsala University, Uppsala, Sweden
and
Research Centre for Zoonotic Ecology and Epidemiology, Kalmar, Sweden

Zoonotic infections are recognised as major human and animal health problems worldwide. However, studies on the epidemiology, ecology and evolution of these parasitic organisms are often limited by the lack of facilities for experimental studies of natural host-pathogen interactions. In part, the lack of such research facilities could be explained by the costs for creating and maintaining high standard animal housing and associated laboratories for experimental work with BSL-2 and BSL-3 pathogens. We claim that some very important basic as well as applied studies require experiments with certain pathogens in their natural hosts, and that such research is crucial to our understanding of the evolution, spread, and maintenance of zoonotic infections affecting human health in nature.

We are a group of 16 researchers from Umeå University, Uppsala University, Kalmar University, Lund University, the Karolinska Institute, and Kalmar County Hospital [who] have decided to take a joint action for creating an independent research facility for experimental studies on zoonotic pathogens in wild and domesticated birds and mammals. Although we are working in many different disciplines including virology, bacteriology, parasitology, medicine, veterinary medicine, epidemiology, behaviour ecology, population biology, medical entomology and evolutionary biology, there is a common need for an animal research facility for experimental studies using BSL 2 and BSL 3 pathogens in their natural bird and mammal host species.

At our first major meeting in October 2000, we decided that such a Research Centre for Zoonotic Ecology and Epidemiology (RCZEE) facility should be located on the Island Öland on the Swedish east coast, that it should be created for experimental work with viruses, bacteria and protozoa of BSL 2 and 3 in wild and domesticated birds and mammals, that the containment animal house(s) should be designed for work with mammals in the size from mouse to cattle and for birds in the size from warblers to geese, that there should be breeding facilities for some of the animal species, and that there should be appropriate laboratory facilities for basic virological, bacteriological and parasitological work. We also decided that the RCZEE should be open not only to Swedish scientist but also to scientists from other European countries.

We feel that this is a unique initiative in a European perspective as well as in a larger international perspective. Such a research facility could open the door for a multidisciplinary approach in the study of epidemiology, ecology, and evolution of an important group of human and animal pathogens. It would be extremely helpful if you could provide information on other facilities, worldwide, that are suited for experimental studies of BSL 2 and 3 pathogens in their natural vertebrate host species. Also, we would like to get in touch with individual researchers as well as research groups that have use for such a research facility.

----
Jan O Lundström, B.Sci., Dr.Med.Sci.
Assistant Professor
Department of Population Biology
Evolutionary Biology Centre
Uppsala University
Norbyvägen 18D
SE-75236 Uppsala, Sweden
email: Jan.Lundstrom@ebc.uu.se
http://ebc.uu.se/popbio/homepage/mainsv.html

and

Research Centre for Zoonotic Ecology
and Epidemiology (RCZEE)
c/o Department of Infectious Diseases
Kalmar County Hospital
SE-39185 Kalmar, Sweden
http://www.rczee.org/






Replies on the RCZEE anouncement
in ProMed 2001


Bill Keevil 010214

I read with interest your advertisement in Promed about the zoonotic research facility. I should like to know more and discuss possible collaboration, perhaps pursuing joint EC funding. My current research involves E. coli O157, Salmonella, Campylobacter, Listeria and Cryptosporidium. It would be important to know more about natural animal reservoirs, routes of infection, infective dose etc. and we hope to initiate new work on Giardia next year.

Coincidentally, I am speaking at the Uiversity of Uppsala, around 13-14th May. Can we meet there?

Yours sincerely
Bill Keevil

Prof C. William Keevil FIBiol FAAM
School of Biological Sciences
Biomedical Sciences Building
University of Southampton
Bassett Crescent East
Southampton SO16 7PX
UK

Office tel: 44 (0) 2380 594726
Lab tel: 594257
fax: 594459
bill.keevil@btinternet.com


Antony Della-Porta 010214

Dear Jan,

It was very interesting to read your message in ProMed and to hear about the new facility that you are planning. Our facility has large animal accommodation ranging from P2 to P4 and we have research on a wide range of zoonotic pathogens, mainly of viral origin. We are the Australian Animal Health Laboratory, a large high containment facility constructed by the Australian Government and opened in 1985. You can view our homepage on www.csiro.au/aahl <http://www.csiro.au/aahl> . You will find a link to an information sheet on our biocontainment on that homepage.

Our principle focus is on the diagnosis of diseases of domestic livestock. This includes cattle, sheep, pigs, chickens, goats, horses and other production animals. Many of these diseases are zoonotic diseases, including Australian bat lyssavirus, Japanese B encephalitis, Menangle virus, Newcastle disease virus, rabies and rabies-related viruses, Swine vesicular disease, vesicular stomatitis, Bacillus anthracis, Brucella abortis, Brucella melitensis, Brucella canis and Brucella suis. In addition, it was our laboratory that first characterised Hendra virus (equine morbillivirus) and carried out transmission studies in a range of animals. This work was done at P4 using fully contained positive pressure suits which were chemically decontaminated, as used at Centers for Disease Control, Atlanta. We also worked with CDC and Malaysian colleagues on the characterisation of Nipah virus and its transmission. Hendra, Nipah, Menangle and Australian bat lyssavirus are all transmitted by fruit bats, and we have carried out transmission studies in fruit bats for some of these viruses at P3 and P4 containment levels. We have also carried out infection studies for other agents at P3 in a wide range of Australian native animals including macropods.

Research at AAHL has extended into studies of disease of wildlife, including kangaroos (kangaroo blindness caused by orbiviruses), decline in frog populations around the world (involvement of chytrid fungal infection). You can find a wide range of publications and information leaflets through our homepage.

There is a range of laboratories in the agriculture area that are constructed to P3. Only AAHL and a new Canadian laboratory at Winnipeg are constructed to P4. Other P3 laboratories that might be of assistance are the US Department of Agriculture's laboratories at Ames and Plum Island, the Animal Virus Research Institute at Pribright, UK, the Lleystad laboratory, Netherlands, and a small range of other laboratories. As far as I know, they don't usually work with wildlife, except perhaps for hosts of rabies.

We would be willing to provide some assistance and advice on the design of your proposed facility. We have a biocontainment engineer, a Microbiology Security Group and an Engineering Services Group with extensive experience in biocontainment and plant design and operation. We have provided advice to a wide range of groups involved in the design and operation of biocontainment facilities, including CDC, the USDA, Swiss, Japanese and Hong Kong groups. We have also provided extensive advice on the design and operation of a number of animal quarantine facilities. We also have a wide range of operating protocols that you might find of use. One of the most critical factors in the operation of any facility working with zoonotic agents is the safety of staff, and the manner in which the staff operate is critical to their safety.

Again, I wish you every success in the development of your facility. If you want us to provide any advice and assistance, please don't hesitate to contact me.

Regards,

Tony Dr. Antony Della-Porta
FASM Manager Technical and Support Services,
CSIRO Livestock Industries, Australian Animal Health Laboratories, Private Bag 24, Geelong, Vic., 3220, Australia
Tel +61 3 5227 5015 Fax +61 3 5227 5250
Email Antony.Della-porta@li.csiro.au


Brian Hjelle 010214

Dear Jan,

I'm not sure that I understand exactly what you are looking for but you may want to know that we have developed an outdoor "BSL4" equivalent lab (a lab wherein we can infect deer mice with Sin Nombre hantavirus in an outdoor setting experimentally, which othewise would require a BSL4 lab). I've attached an article about it.

Hope this is helpful.

Brian Hjelle

Brian Hjelle, M.D.
Infectious Diseases and Inflammation Program
Departments of Pathology, Biology, and Molecular Genetics & Microbiology University of New Mexico School of Medicine
Room 329-CRF
915 Camino de Salud NE
Albuquerque, NM 87131-5301 +1 (505) 272 0624 fax +1 (505) 272-9912
bhjelle@salud.unm.edu
http://hsc.unm.edu/infect/faculty.htm
http://thor.unm.edu/Hanta/Website1.htm

PDF-FILE


Andy Hopkins 010214

Dr. Lundstrom:

This web site (http://www.arserrc.gov/naa/Home/research.htm) of the US Department of Agriculture has links to several of the USDA animal research sites in the US, particularly the one on Plum Island (http://www.ars.usda.gov/plum/) which is one of the primary places for animal zoonosis research in the US and has facilities for handling large animals. Zoonosis research in the US seems to be divided between animals zoonosis which are the purvey of the agriculture department and zoonoses which affect humans, the purvey of CDC. However, we have been involved in some predominantly animal disease such as Rift Valley Fever and Nipah.

There is quite a bit of new construction of BSL-3 and 4 labs going on at CDC at this time. I can put you in touch with some of the people involved in the design and planning of those facilities if that would be useful to you.

Andy Hopkins
Special Pathogens Branch Centers for disease control
Atlanta Georgia USA 404-639-1720


Dr.D.D.Joshi 010214

Dear Dr. Jan O Lundstrom,

Thanks for your email message through Promed I received on 10 Feb.2001.

Our centre is interested to do research work on Zoonotic diseases here in Nepal. Since last 10 years we have been doing this work.

We would like to participate in your research work. Please kindly give us detail information so that we can think and colloborate with your institute.

I look forward to hearing from you.

With best regards.

Yours sincerely

Dr.D.D.Joshi
Director National Zoonoses and Food Hyigene Research Centre
Tahachal, G.P.O.Box 1885,Kathmandu, Nepal
Phone+977-1-270667,Fax:+977-1-272694

 


                |   last modified Friday, June 13, 2003